Health Canada's use of its priority review process for new drugs: a cohort study
Objectives Priority reviews of new drug applications are resource intensive and drugs approved through this process have a greater likelihood of acquiring a serious safety warning compared to drugs approved through the standard process. Therefore, when Health Canada uses priority reviews, it is impo...
Saved in:
Main Author: | Joel Lexchin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2015-05-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/5/5/e006816.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
What are the respiratory health research priorities in Alberta, Canada? A stakeholder consultation
by: Michael K Stickland, et al.
Published: (2022-06-01) -
Strategies and resources used by public health units to encourage COVID-19 vaccination among priority groups: a behavioural science-informed review of three urban centres in Canada
by: Tori Langmuir, et al.
Published: (2025-01-01) -
Reducing the Adverse Impact of Injection Drug Use in Canada
by: Kevin B Laupland, et al.
Published: (2012-01-01) -
BOLOGNA PROCESS: EVOLUTION OF PRIORITIES AND INTERIM RESULTS
by: Gennady F. Tkach, et al.
Published: (2016-12-01) -
Translation of oral health research priorities into research topics in an equity-based priority setting exercise
by: Sumanth Nagraj Kumbargere, et al.
Published: (2025-01-01)